External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

MDS 2024

-
Coming soon
05:00 PM
Duration 2hrs Philadelphia, USA
Parkinson's Disease Burden in Underserved Populations Across the US in 2022
Stacey L. Kowal, Katherine L. Rosettie, Elizabeth S. Mearns, Nikki Win, Helen Lin, Bruno Musch

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:00 PM
Duration 2hrs Philadelphia, USA
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants with Early Parkinson's Disease (PADOVA): Rationale, Design, and Baseline Data
Tania Nikolcheva, Gennaro Pagano, Nathalie Pross, Tanya Simuni, Kenneth Marek, Ronald B. Postuma, Nicola Pavese, Fabrizio Stocchi, Klaus Seppi, Gesine Respondek, Annabelle Monnet, Nima Shariati, Loes Rutten-Jacobs, Thomas Kustermann, Kirsten I. Taylor, Dylan Trundell, Hanno Svoboda, Azad Bonni, Paulo Fontoura, Rachelle Doody

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 2hrs Philadelphia, USA
Effect of Prasinezumab on Parkinson’s Disease Motor Progression in a Long-term Open-label Extension of the PASADENA Trial
Gennaro Pagano, Annabelle Monnet, Adriana Reyes, Benjamin Ribba, Hanno Svoboda, Thomas Kustermann, Tanya Simuni, Ronald B. Postuma, Nicola Pavese, Fabrizio Stocchi, Kathrin Brockmann, Krzysztof Smigorski, Valentina Gerbaldo, Paulo Fontoura, Rachelle Doody, Geoffrey A. Kerchner, Patrik Brundin, Kenneth Marek, Azad Bonni, Tania Nikolcheva

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar